Because there are typically no symptoms until the first fracture occurs, osteoporosis is considered a silent disease. Some ...

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune ...

While osteoporosis is much more common in adults over age 60, it can strike younger people too. In fact, according to the ...

Madam Kumari, as she is known, has osteoporosis or brittle bones. The condition typically presents without any warning ...

Children with osteoporosis often have a treatment plan that includes medications to strengthen bones or address the ...

Despite being known as an ‘old women’s disease’, osteoporosis poses a significant threat to men’s health, with one in five at ...

Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases, today announced the dosing ...

Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and potential targets for ...

"Angitia doses first subject in Phase II trial of AGA2118 for treating osteoporosis" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

USA: A recent study recommends that lung transplant patients undergo annual screening with dual-energy X-ray absorptiometry ...

Researchers conducted a study to determine if variations in the MTNR1A gene, specifically the MRNR1A variant (rs374152717), could be a genetic cause of idiopathic osteoporosis.